色素性慢性阻塞性肺部疾病. 到目前为止我们知道什么?
Konstantinos Bartziokas1, Andriana I Papaioannou2, Nikoletta Rovina2
1Private Sector, 42131, Trikala, Greece.
异性慢性阻塞性肺病 (COPD) 是一种独特的实体,其中异性可能改善皮质类固醇反应. 针对这种T2高的内型,正在探索向特定白细胞间蛋白的单克隆抗体.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘研究突出显示,在病变发生过程中,有好色素和它的介质 (IL-5,IL-4/IL-13,IL-33).
- 一个COPD亚组表现出血中乙,表明乙性COPD作为一个独特的实体.
- 乙素在COPD病理生理学中的确切作用正在研究中,但它们可能会增强皮质类固醇的有效性.
研究的目的:
- 为了审查COPD中eosinophilia的机制.
- 为了检查埃索诺菲利亚对COPD结果的影响.
- 评估当前关于在COPD治疗中使用外周血液乙氨基的数据.
主要方法:
- 关于COPD中eosinophilic气道炎症的最新文献的综述.
- 分析研究的分析,调查亲埃索诺菲尔介质及其在COPD中的作用.
- 对T2高的COPD中单克隆抗体的临床试验数据的检查.
主要成果:
- 慢性慢性肺炎的乙素,类似于喘,表明一种特定的疾病内型.
- 血中乙氨基酸细胞的数量可以预测COPD的皮质类固醇治疗的反应.
- 针对IL-5,IL-4,IL-13和IL-33的单克隆抗体正在研究T2高的COPD.
结论:
- 乙性COPD代表了一个潜在的可治疗的表型.
- 用单克隆抗体向特定的互白蛋白显示出对控制COPD中异性气道炎症的有希望.
- 周围血液中乙氨基酸细胞的计数对于识别那些可能受益于这些向治疗的患者至关重要.
更多相关视频
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
相关概念视频
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
